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Abstract: Hair pulling disorder (HPD; trichotillomania) is thought to be
associated with significant psychiatric comorbidity and functional impairment.
However, few methodologically rigorous studies of HPD have been conducted,
rendering such conclusions tenuous. The following study examined
comorbidity and psychosocial functioning in a well-characterized sample of
adults with HPD (N=85) who met DSM-IV criteria, had at least moderate hair
pulling severity, and participated in a clinical trial. Results revealed that
38.8% of individuals with HPD had another current psychiatric diagnosis and
78.8% had another lifetime (present and/or past) psychiatric diagnosis.
Specifically, HPD showed substantial overlap with depressive, anxiety,
addictive, and other body-focused repetitive behavior disorders. The
relationships between certain comorbidity patterns, hair pulling severity,
current mood and anxiety symptoms, and quality of life were also examined.
Results showed that current depressive symptoms were the only predictor of
quality of life deficits. Implications of these findings for the conceptualization
and treatment of HPD are discussed.
Keywords: Trichotillomania; Obsessive-Compulsive Disorder; Comorbidity;
Depression; Quality of life

1. Introduction
Hair Pulling Disorder (HPD) is an obsessive-compulsive
spectrum condition in which individuals pull hairs from their own body,
resulting in significant hair loss (American Psychiatric Association,
2013). Subclinical hair pulling is relatively common (i.e., 11%) while
clinical hair pulling, or diagnosable HPD, is less frequent (Woods et al.,
1996). The lifetime prevalence rate of HPD as defined in DSM-IV-TR is
estimated at about 0.6% (APA, 2000), but may be as high as 3.4% for
women and 1.5% for men (Christenson et al., 1991a and Christienson
et al., 1991b). Studies on the gender distribution of HPD suggest it is
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more common in females (9:1; Christenson, 1995, Duke et al.,
2009 and Reeve, 1999).
Research has identified two distinct styles of pulling:
“automatic” and “focused” (Christenson et al., 1991a). Automatic
pulling is a passive process in which pulling occurs with little conscious
awareness. In contrast, focused pulling is an active and purposeful
process, which some suggest, functions to regulate negative affect
and/or aversive cognitions (Woods et al., 2006b). In either case, hair
pulling can create a vicious cycle in which both types of pulling are
present in the same individual: out of awareness (automatic) pulling
leads to emotional consequences (e.g., sadness, anger, and guilt),
which can lead to further (focused) pulling (Diefenbach et al., 2002).
HPD has been consistently associated with negative
psychosocial consequences. Hair pulling is viewed negatively by peers
(Woods et al., 1999), can lead to avoidance of social and recreational
activities (Woods et al., 2006a), and can result in anxiety during
intimate situations (Christenson and Mansueto, 1999, Diefenbach et
al., 2005a and Duke et al., 2010). In addition, individuals with HPD
experience academic, occupational, and psychological difficulties
(Woods et al., 2006a). Research shows that the majority of people
with HPD report feeling physical unattractiveness, depression, shame,
and feelings of low self-worth (Stemberger et al., 2000).
Beyond measuring specific facets of psychosocial functioning in
HPD, researchers have also investigated the relationship between HPD
and global indices of quality of life, with results being mixed. Keuthen
et al. (2004) found no significant differences on quality of life
measures between persons with HPD (N=58) and healthy controls
(from published norms). In contrast, two other studies found that
persons with HPD (n=28 and 70) had poorer quality of life scores than
non-psychiatric controls (n=28 and 25) (Diefenbach et al.,
2005b and Odlaug et al., 2010). Three studies (Diefenbach et al.,
2005b, Keuthen et al., 2004 and Tung et al., 2014) with various
sample sizes (n=28, 58 and 187) found that depression severity
significantly predicted quality of life, even while controlling for hair
pulling severity, and a fourth study (Odlaug et al., 2010) (n=70)
showed that persons with HPD who reported poor quality of life also
reported higher scores on depression indices. Furthermore, in a related
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study examining life disability in HPD (N=153), focused hair pulling
severity and pulling-related distress and interference predicted life
disability while controlling for depression, but depression also
correlated with life disability (Tung et al., 2015). These results indicate
that quality of life and HPD might be at least partially mediated
through an association with depression.
Given the difficulties in psychosocial functioning experienced by
persons with HPD, perhaps it is not surprising that HPD patients are
generally believed to suffer from comorbid psychiatric disorders at a
higher rate than the general population. In reviewing the HPD
literature, 20 studies reported comorbidity rates in adults with HPD,
but these rates varied widely from study to study. For example, rates
for comorbid depressive disorders ranged from 14% to 60%
(Christenson and Mansueto, 1999, Keijsers et al., 2006, van Minnen et
al., 2003 and Odlaug et al., 2010), anxiety disorders from 2.3% to
57% (van Minnen et al., 2003 and Christenson et al., 1991a), and
OCD from 5% to 27% (Christenson et al., 1991a and Schlosser et al.,
1994). It is unclear what factors contributed to these inconsistencies,
but many of the studies reporting comorbidity rates in HPD possess
methodological limitations. First, some studies used unstructured
assessment instruments (e.g., Christenson et al.,
1991a and Christienson et al., 1991b) or (online) self-report measures
(e.g., Woods et al., 2006a). Second, some studies reported current
comorbid disorders, while others reported on lifetime comorbidity.
Third, not all studies were published in peer-reviewed journals (Hand
et al., 1996). Finally, some study samples did not consist entirely of
persons with HPD and failed to report statistics specifically for HPD
(e.g., Grant and Christenson, 2007).
After 4 studies with significant limitations were set aside, there
remained 16 studies of sufficient methodological scrutiny that report
comorbidity rates in HPD. These studies were all published in peerreviewed journals, used structured or semi-structured diagnostic
assessments, used samples that clearly consisted of individuals with
HPD, and provided clearly delineated results for specific diagnoses
(e.g., “major depression” rather than “mood disorder”). A summary of
the characteristics of these studies and their data are presented in
Table 1, Table 2 and Table 3. Visual analysis of these tables showed
that comorbidity rates and study characteristics (i.e., sample sizes)
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still vary considerably across studies. This variability could have been
caused by the fact that several diagnostic classification systems were
used in these studies. Also, most studies did not report data on many
comorbid disorders. Finally, these studies used a variety of recruitment
practices, meaning that selection bias likely impacted comorbidity
rates.
Table 1. Description of former studies examining comorbidity in HPD.
Reference

Sample
size

Recruitment

Assessment

Christenson et al.,
1991a and Christienson et al.,
1991b

60

Referrals from outpatient or
respondents to newspaper
ads. Study completed at a
trichotillomania specialty
clinic.

Semi-structured interview
based on DSM-III-R for HPD
and comorbid disorders

Swedo and Leonard (1992)

43

Participants who had
presented for research studies
at the National Institutes of
Mental Health

Schedule for Affective
Disorders and Schizophrenia –
Lifetime Version and the
Diagnostic Interview for
Children and Adolescents
(based on DSM-III-R)

Schlosser et al. (1994)

22

Participants recruited through
a psychiatric outpatient clinic
(N=8) and newspaper
advertisements (N=14)

Semi-structured interview
focused on hair pulling,
Diagnostic Interview Schedule
for Axis I Disorders, and
Structured Interview for DSMIII-R Personality Disorders

186

Patients presented at a
Trichotillomania Clinic

Minnesota Trichotillomania
Assessment Inventory based
on DSM-III-R

van Minnen et al. (2003)

43

Recruited through television
SCID for DSM-IV
ads. Self-referred to university
outpatient clinic.

Keijsers et al. (2006)

28

Waitlist control group from
van Minnen et al. (2003)

SCID for DSM-IV

Lochner et al. (2005)

54

Referred to the research unit
from a wide range of sources
(e.g., OCD Association of
South Africa, communitybased primary care
practitioners, and
psychiatrists).

Semi-structured clinical
interview and SCID-I

Diefenbach et al.,
2005a and Diefenbach et al.,
2005b

28

Recruited for participation in
treatment study

TDI and SCID

Unclear

SCID

Recruited from ongoing
pharmacological treatment
studies and a longitudinal
study on impulse control
disorders

SCID-I and semi-structured
interview

Christenson (1995)

Woods et al., 2006b and Woods 28
et al., 2006
Odlaug and Grant (2008)

24
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Reference

Sample
size

Recruitment

Assessment

Grant et al. (2009)

50

Recruited through newspaper Physician-administered TDI
ads and referrals from medical and SCID
providers

Lochner et al. (2010)

80

Referred to the research unit
from a wide range of sources
(e.g., OCD Association of
South Africa, communitybased primary care
practitioners, and
psychiatrists).

SCID-I/P, SCID-II/P, SCIDOCSD, and Trichotillomania
Behavior Profile

Odlaug et al. (2010)

70

Participants recruited from
completed clinical trials

SCID and SCID-compatible
modules for impulse control
disorders

Keuthen et al. (2012)

38

Unclear

Semi-structured interviews for
DSM-IV diagnoses. Minimum
MGH-HPS score of 10, HPD
symptoms for at least 1 year

Lochner et al. (2012)

84

Self-referred to specialty
clinics

SCID-I/P for DSM-IV and
proposed DSM-5 criteria

153

Participants recruited for two
research studies at
Massachusetts General
Hospital.

SCID for DSM-IV-TR Axis I
Disorders Non-patient Edition
(SCID-I/Np) and Keuthen
Diagnostic Inventory for Skin
Picking (K-DISP)

Tung et al. (2015)

Table 2. Current comorbidity rates in former studies.
Disorder Christenson et al., Schlos
Diefenbach et
Wood Gran Odla Lochn Odla Tung Avera
1991a and Christi ser et
al.,
s et
t et ug et er et ug et et al.
ge
enson et al.,
al.
2005a and Diefe
al.
al.
al.
al.
al. (201
1991b
(1994)
nbach et al.,
(2006 (200 (201 (2012 (201
5)
2005b
a)
9)
0)
)
0)
Excoriat –
ion
disorder

–

–

–

–

–

–

–

21.6

21.6

–

–

–

–

–

5

0

22.9

9.3

18

21.4

28.6

28

–

8

0

9.4

17.1

Dysthy –
mia

–

–

–

–

–

5

–

2.7

3.9

Bipolar –

–

–

–

–

–

0

–

0.7

0.4

14

3.6

3.6

–

–

2

–

4.6

5.6

Social –
phobia

–

–

–

–

–

5

–

0.1

2.6

Specific –
phobia

–

–

–

–

–

12

–

6

9

OCD

–

Major 23
depressi
on

Panic –
disorder

GAD

–

–

–

–

–

–

14

–

16.6

15.3

PTSD

–

–

3.6

–

–

–

0

–

3.3

2.3

Eating –
disorder

5

–

–

–

–

1

–

4.6

3.5

Substan –
ce use
disorder

14

–

–

–

0

–

4.2

3.3

5.4
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Disorder Christenson et al., Schlos
Diefenbach et
Wood Gran Odla Lochn Odla Tung Avera
1991a and Christi ser et
al.,
s et
t et ug et er et ug et et al.
ge
enson et al.,
al.
2005a and Diefe
al.
al.
al.
al.
al. (201
1991b
(1994)
nbach et al.,
(2006 (200 (201 (2012 (201
5)
2005b
a)
9)
0)
)
0)
Psychoti –
c
disorder
NOS

–

–

–

–

18

–

–

–

18

Table 3. Lifetime comorbidity rates in former studies.
Disorder

Christenson et al., Swedo Christens Schloss Lochn Odlau Lochn Keuth Tung Avera
1991a and Christie
and
on
er et al. er et g and er et en et et al.
ge
nson et al., 1991b Leona (1995)
(1994)
al.
Grant
al.
al.
(201
rd
(2005 (200 (2010 (2012
5)
(1992
)
8)
)
)
)

Excoriati –
on
disorder
OCD

–

–

–

–

–

–

24.2

24.2

16

13.4

27

–

8.3

7.5

–

30.1

15.3

Major 32
depressi
on

39

51.6

41

49

41.7

–

34.2

55

42.9

Dysthym –
ia

–

4.8

36

2

–

–

–

2.7

11.4

Bipolar –
disorder

5

2.7

–

–

0

–

–

1.3

2.3

Panic
18
disorder

5

20.8

27

6.1

–

–

2.6

11.3

13

–

–

11.3

–

8.2

–

–

2.6

10

7.4

Specific –
phobia

2

18.8

–

18.4

–

–

2.6

6.6

12.1

Social
phobia

5

–

GAD

–

32

27

32

20.4

–

–

–

16.6

25.6

PTSD

–

–

–

23

–

–

–

–

9.9

16.5

Anorexia –

5

1.6

5

2

–

–

–

4

3.5

Bulimia –

–

8.1

14

6.1

–

–

5.3

2

7.1

–

–

–

–

10.2

–

–

–

6

8.1

Alcohol –
use
disorder

–

19.4

5

–

–

–

2.6

–

8.9

Substanc 22
e use
disorder

15

16.1

18

–

8.3

–

–

21.2

16.8

Binge
Eating

Due to the limitations of the literature on comorbidity rates in
HPD, there is a need to characterize comorbidity patterns in persons
with HPD using larger and well-characterized samples with
psychometrically sound and rigorous assessment instruments. These
results can then be compared to those of previous research in order to
create better-established norms of HPD comorbidity. The current study
reports on comorbidity data from a recently completed, federally
funded clinical treatment trial of adults with HPD (R01MH080966;
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Woods, PI) that includes one of the top three largest samples of HPD
collected to date. In addition to describing patterns of comorbidity, the
relationship between psychiatric comorbidity and psychosocial
functioning in persons with HPD are explored.

2. Method
2.1. Participants
Eighty-five adults with HPD participated in a randomized
controlled trial comparing the relative efficacy of Acceptance-Enhanced
Behavior Therapy to supportive psychotherapy. Participants were
recruited via local newspaper ads, public transportation flyers,
newsletters, website advertisements via the Trichotillomania Learning
Center, and clinic referrals to a university-based HPD specialty clinic.
The recruitment advertisements stated:
Are you an adult between the ages of 18 and 65 who pulls their
hair? If you do, you may be eligible to participate in a research study.
The Psychology Department at the University of Wisconsin-Milwaukee
is conducting research on the effectiveness of non-drug treatments for
hair pulling in adults. The study will take up to 9 months to complete,
treatment is free, and participants will be paid up to $200 for their
participation in the study. For more information, please call…
Inclusion criteria included: (1) a current DSM-IV-TR diagnosis of
HPD, based on a semi-structured clinical interview; (2) a
Massachusetts General Hospital Hairpulling Scale score of ≥12; (3) a
Wechsler Test of Adult Reading score of ≥85; (4) age 18–65; (5)
ability to speak English fluently; (6) judged able to be maintained on
outpatient status for the duration of treatment; (7) no initiation or
change in the dosage of any psychotropic medication for up to eight
weeks preceding participation in the study or during the course of the
study; and (8) not currently receiving psychotherapy for HPD or
another psychiatric condition.
Exclusionary criteria included: (1) a positive diagnosis of bipolar
disorder, psychotic or neurocognitive disorder, substance dependence
(with the exception of nicotine dependence), intellectual disability, or
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pervasive developmental disorder; and (2) a primary diagnosis of a
mood or anxiety disorder. In addition, individuals who admitted
ingesting hair after pulling were eligible for participation only after
they had received a physical exam from their primary care physician to
determine if there was any gastrointestinal blockage requiring more
immediate care. One exception to exclusion criteria was made. A
single individual who had experienced several periods of depression
and a single hypomanic episode, thus meeting criteria for Bipolar II,
was allowed to participate the study after the evaluators and principal
investigator discussed the case.
Ninety-one participants (92.2% female; mean age=35.39)
completed the baseline assessment battery. Most were Caucasian
(82.3%), 12.9% were Black or African American, 1.2% were Asian,
1.2% were Hispanic, and 3.5% identified as Other.

2.2. Measures
The study utilized a screening questionnaire to assess many
self-reported aspects of participants' demographics and psychosocial
functioning. Additionally, several standardized assessment measures
were used.

2.2.1. Diagnosis
The Structured Clinical Interview for DSM-IV Patient Version
(SCID-P; First et al., 2002) was used to evaluate the presence of
comorbid psychiatric disorders. The interview provides the trained
rater with standardized probes about symptoms of DSM-IV disorders
and provides a scoring algorithm for DSM-IV diagnosis. The SCID-P
examines both lifetime (present and past) and current diagnoses.
Lifetime comorbidities were given if the participant met criteria for a
past and/or current diagnosis. Comorbidities assessed in this study
were limited to those covered in the SCID-P, as well as HPD and skin
picking. This study did not assess for Attention Deficit/Hyperactivity
Disorder, sexual disorders, and personality disorders.
The Trichotillomania Diagnostic Interview (TDI; Rothbaum and
Ninan, 1994) is a six-item interview that is modeled after the
Structured Clinical Interview for the DSM-III-R. Although no
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psychometric data are available for this instrument, it offers a
structured method for assessing the presence or absence of HPD, and
is commonly used to diagnose HPD (e.g., Grant et al., 2009, Tolin et
al., 2007 and Diefenbach et al., 2008).

2.2.2. Hair pulling severity
The Massachusetts General Hospital Hairpulling Scale (MGHHPS; Keuthen et al., 1995 and O’Sullivan et al., 1995) is a widely used
self-report severity measure of HPD consisting of two factors:
“Severity” and “Resistance and Control” (Keuthen et al., 2007). The
MGH-HPS has 7 items that are scored on a 5-point Likert scale for a
total ranging from 0 to 28, with higher scores reflecting greater hair
pulling severity, lower resistance to pulling, and less control over
pulling. It has demonstrated satisfactory psychometric properties
( Diefenbach et al., 2005a, Keuthen et al., 1995 and O’Sullivan et al.,
1995).
The National Institutes of Mental Health Trichotillomania
Severity Scale (NIMH-TSS; Swedo et al., 1989) is a semi-structured
clinical interview that asks questions about time spent pulling,
resistance to pulling urges, distress, and impairment. Possible scores
range from 0 to 25. The scale has shown adequate psychometric
properties for assessing HPD in both adults and children ( Diefenbach
et al., 2005a, Franklin et al., 2011, Stanley et al., 1999 and Swedo et
al., 1989).

2.2.3. General psychological functioning
The Quality of Life Inventory (QOLI; Frisch et al., 1992) is a 32item self-report measure that assesses raters' satisfaction with 16 life
areas. The reliability of the QOLI is adequate, with a temporal stability
rating of 0.73 and coefficient alpha of 0.79. The measure has also
demonstrated adequate convergent and discriminant validity. QOLI tscores were used in the present analyses and scored according to
Frisch (1992).
The Beck Anxiety Inventory (BAI; Beck et al., 1988b and Beck
et al., 1988a) and The Beck Depression Inventory (BDI; Beck, 1972)
are widely used to assess anxiety and depression, respectively. Both
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measures demonstrate strong psychometric properties (Fydrich,
Dowdall, & Chambless, 1992; Beck et al., 1988b and Beck et al.,
1988a).

2.3. Procedure
A multi-gate assessment procedure was used to screen
participants for eligibility into the study. First, patients were screened
by telephone. All callers to the HPD clinic were provided information
about the study and screened for possible participation. If the
participant appeared to be eligible and interested, he or she was
scheduled for an initial clinic screening, during which consent was
obtained and inclusion/exclusion criteria checked. Participants deemed
ineligible or those not wishing to participate were referred for standard
clinical services. Over two hundred individuals (274) were screened via
telephone. Of the 157 who were screened out at the phone stage, 30
reported having exclusionary diagnoses (24 for bipolar, 4 for
schizophrenia, 1 for intellectual disability, and 1 for dementia) and
were never formally assessed for HPD. Within the 117 persons who
passed the phone screen and came into the clinic for the in-person
screen, 21 were ineligible. Reasons included subthreshold level of hair
pulling severity (n=13), lacking an HPD diagnosis (n=5), below
minimum intelligence (n=1), and primary diagnosis of another mental
disorder (n=2; i.e., mood disorder). Another 6 participants were lost
between screening and baseline assessment due to inability to reestablish contact.
IRB approval for this project was obtained at Texas A&M
University (IRB2013-3025) and the University of Wisconsin-Milwaukee
(IRB09.039), and the study is publicly listed on ClinicalTrials.gov
(#NCT00872742). The study was performed in compliance with the
Code of Ethics of the World Medical Association (Declaration of
Helsinki). Data for this manuscript were obtained from the baseline
assessment of the treatment trial.

3. Results
3.1. Hair pulling and psychosocial functioning
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The baseline sample reported moderately severe hair pulling
according to both the MGH-HPS (M=16.93, SD=4.53) and NIMH-TSS
(M=14.34, SD=3.64).

3.2. Comorbidity
According to the SCID-P (Table 4), the majority of patients
(78.8%) met criteria for at least one lifetime comorbid psychiatric
condition, and 38.8% were determined to be currently suffering from
another Axis I disorder. The most common lifetime comorbid
conditions were Major Depression, Alcohol Abuse, PTSD, and GAD. The
most common current comorbid conditions were Excoriation Disorder
and Generalized Anxiety Disorder, followed by Specific Phobia and
Obsessive-Compulsive Disorder.
Table 4. Comorbidity rates in the present sample.
Diagnosis

Current (%) (N=85) Lifetime (%) (N=85)

Excoriation

12.9

12.9

OCD

4.7

7.1

Major depression

3.5

51.8

Adjustment disorder with depressed mood 2.4

3.5

Dysthymia

2.4

2.4

Bipolar

1.2

1.2

Panic

1.2

8.2

Social phobia

4.7

8.2

Specific phobia

5.9

8.2

GAD

12.9

14.1

PTSD

1.2

15.3

Anorexia

0.0

4.7

Bulimia

0.0

1.2

Binge eating

0.0

1.2

Alcohol abuse disorder

2.4

17.7

Substance abuse disorder

0.0

4.7

Total

38.8

78.8

The most notable differences between data from this study and
average current comorbidity rates from previous studies (See Table 2,
Table 3 and Table 4; current study data reported first) were on
Excoriation Disorder (12.9% vs. 21.6%), Major Depression (3.5% vs.
17.1%), and Obsessive-Compulsive Disorder (4.7% vs. 9.3%).
Additionally, notable differences for our data and the average lifetime
comorbidity rates from previous studies were on Excoriation Disorders
(12.9% vs. 24.2%), OCD (7.1% vs. 15.3%), Specific Phobia (2.4% vs.
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12.1%), GAD (14.1% vs. 25.6%), Alcohol Abuse Disorder (17.7% vs.
8.9%), and Substance Abuse Disorder (4.7% vs. 16.8%).

3.3. Effects of comorbidity, psychosocial functioning,
and hairpulling on quality of life
In order to investigate associations between comorbidity, hair
pulling variables, and measures of psychosocial functioning, we
conducted multiple correlational analyses comparing BAI, BDI, MGH,
NIMH-TSS, and the presence of current or lifetime comorbidity to QOLI
scores. A full correlation matrix is shown in Table 5. Both Pearson and
point-biserial correlations were used, and due to the propensity for
multiple comparisons to increase Type I error rates, we used a
Bonferroni correction to adjust alpha levels. Only BDI scores were
significantly correlated with the QOLI. This suggests that, in persons
with HPD, current depressive symptom severity is the best predictor of
current ratings of quality of life.
Table 5. Correlation matrix.
MGHHPS
MGH-HPS

–

NIMH-TSS

0.62

BAI

0.19

BDI

NIMHTSS

BAI

BDI

Current
comorbidity

Lifetime
comorbidity

−

–

–

–

–

–

–

–

–

–

0.23*

–

–

–

–

0.25*

0.24*

0.71** –

–

–

Current
comorbidity

0.02

0.03

0.16

0.22

–

–

Lifetime
comorbidity

0.02

0.06

0.22*

0.25*

0.41**

–

−0.09

−0.09

−0.13 −0.34** −0.17

Quality of life

**

−0.19

**Denotes bonferroni-corrected significance at p<0.002.
*Denotes significance at p<0.05.

4. Discussion
The aims of the current study were to describe psychosocial
functioning and comorbid psychopathology within a well-characterized
sample of adults with HPD with moderate hair pulling severity and to
investigate the relationships between these variables and quality of
life.
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In this study, persons with HPD reported quality of life in the
upper part of the low range, which was very similar to that reported by
three previous studies utilizing the same measure (Raw score means
on the QOLI=41.20 vs. 43.00, 44.31, 42.77; Diefenbach et al.,
2005b and Odlaug et al., 2010; Tung, personal communication,
October 4, 2015). The findings on current levels of depressive and
anxiety symptoms are not as consistent with previous findings. This
study showed current depressive and anxiety symptoms to be within
the minimal to mild range, along with a high degree of variance.
Although these findings are consistent with that of several studies
(Diefenbach et al., 2005b and Keuthen et al., 2004, 2012; Odlaug et
al., 2010), they contrast with Woods et al. (2006a), who reported
mean depression and anxiety scores in the severe range on the
Depression Anxiety Stress Scale (DASS-21; Lovibond and Lovibond,
1995). Perhaps the Woods et al. (2006a) study, which utilized an
internet sample of self-identified HPD participants, found higher rates
of depressive and anxiety symptoms due to sampling differences, such
that persons with HPD who participate in internet-based surveys may
be more secretive and impaired than those who are willing to
participate in a clinical trial.
In reviewing the literature, we found vastly differing rates of
comorbidity among people diagnosed with HPD. In the current study,
rates of both lifetime and current psychopathology were high, at
78.8% and 38.8%, respectively. These rates are elevated as compared
to community norms, as studies have shown that, in a representative
community U.S. adult sample, we should expect to find 46% lifetime
and 26% twelve-month prevalence of at least one psychiatric disorder
(Kessler et al., 2005b and Kessler et al., 2005a). Specifically, this
study found high rates of comorbid ExD, Generalized Anxiety Disorder,
Specific Phobia, Major Depression, PTSD, as well as other anxiety and
addictive disorders. One finding that has notable implications is that
comorbid OCD was shown in 7.1% of individuals over their lifetime.
Proponents of the OCD-spectrum, including HPD, have proposed that
shared comorbidity is evidence of this relationship, yet our findings
stand in contrast to such arguments. Evidence from other studies on
comorbidity rates between OCD and HPD has been mixed, as expert
reviews have pointed to poor evidence for high comorbidity rates
(Storch et al., 2008) while the literature review conducted in the
current study points to high rates of current and lifetime comorbidity.
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The results from the current study and the mixed findings in the
literature suggest that more research is needed on the topic.
There were several notable differences between the comorbidity
rates found in the current study and those in the HPD literature. The
direction of those differences was largely in the direction of lower
estimates of current and lifetime comorbidity in the current study as
compared to those reported in previous studies. Although the clinical
trial from which these data were derived did exclude a number of
individuals with comorbid diagnoses, most exclusions came because of
self-reported bipolar disorder during the phone screen. Only two
individuals were excluded for a primary diagnosis of severe
depression. Differences in the rates of Excoriation Disorder between
our study and that of Tung et al. (2015) might seem large, but a
review by Snorrason et al. (2012) showed that comorbidity rates
between HPD and Excoriation fall between 10% and 34%
(average=20.8%). Thus, our rate of Excoriation disorder might be
below average, but not outside the range of other studies. One
potential reason why lower rates of mood, anxiety, and substance use
disorders were found in the current study is that individuals with HPD
in addition to these diagnoses may seek treatment for HPD less
frequently than persons with HPD alone. While experiencing the effects
of depression, anxiety, or drug addiction, individuals might view hair
pulling as a relatively minor problem and be unlikely to seek HPDspecific treatment. Thus, individuals with HPD who seek treatment for
HPD might be less likely to be suffering from other conditions, whereas
the more complicated group of persons with HPD exist in less
specialized settings. This notion could be seen as consistent with critics
of the methodology of randomized clinical trials (Westen et al., 2004),
in that they tend to recruit individuals who lack treatment-complicating
characteristics such as psychiatric comorbidity, making it difficult to
generalize their results to real-world settings.
Although HPD is indeed associated with other psychosocial
conditions, comorbid diagnoses and hair pulling symptoms do not
seem to account for deficits in global functioning. Instead, it appears
that current internalizing symptoms largely account for reductions in
quality of life, a finding that is consistent with those of previous
studies (Diefenbach et al., 2005b, Keuthen et al., 2004, Odlaug et al.,
2010, Tung et al., 2014 and Tung et al., 2015). It must, however, be
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noted that the variable correlating significantly with quality of life,
depression, was measured continuously and allowed to freely vary,
whereas some other variables were constrained due to inclusion
criteria (i.e., MGH≥12). This practice could have attenuated the
correlation between hair pulling severity as measured by the MGH.
Thus, a more diverse community and clinical sample of persons with
HPD and subclinical hair pulling might provide different results.
The current study has a number of implications for future
research. First, future investigations should seek to understand
individuals with HPD who have relatively high psychosocial functioning
aside from hair pulling. Understanding factors contributing to
emotional and functional resiliency in the face of moderate to severe
hair pulling could have important implications for predicting outcomes
and enhancing treatment. Second, results might clarify how and when
selective serotonin reuptake inhibitors (SSRIs) should be prescribed
for persons with HPD. Currently, SSRIs are routinely used to treat HPD
(Woods et al., 2006a) despite little data supporting their effectiveness
(Bloch et al., 2007 and McGuire et al., 2014). Data from the current
study suggest SSRIs may help improve QOL by reducing depressive
symptoms, even if the medications do little to the pulling symptoms.
However, even though it has been proposed that individuals with HPD
who display comorbid mood and anxiety issues may be ideal
candidates for combined behavioral and pharmacotherapy (Dougherty
et al., 2006), combined pharmacological and behavioral treatment
does not always produce enhanced results, as evidenced by treatment
studies for OCD (Foa et al., 2005). Third, it is conceivable that
comorbidity rates might decrease as a result of changes in HPD
diagnostic criteria from DSM-IV to DSM-5. Because DSM-5 removed
two criteria, this would likely result in more hair pullers receiving the
HPD diagnosis. Persons with less severe hair pulling would now be
diagnosed in greater numbers, and these persons would be expected
to show reduced rates of comorbid anxiety and depression, which are
thought to often come as a consequence of hair pulling (Diefenbach et
al., 2002, Keuthen et al., 1998 and Keuthen et al., 2001).
The primary limitation of this study is that potential participants
were screened out for some comorbidities that might impact treatment
(e.g., mania, psychosis, and primary major depression), which creates
selection bias that undoubtedly affects the results of this study. A
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related concern is that all individuals in the current study were seeking
treatment for HPD, which could result in an over-estimation of the
amount of comorbidities, as these persons are more likely to seek help
(Du Fort, Newman, and Bland, 1993). Ultimately, in order to provide
the best estimates of comorbidity, in a TTM community-based
population, researchers would need to conduct a broad survey of the
community that reduced selection bias, but HPD was left out of such
efforts that have already been conducted (i.e., the National
Comorbidity Study).
Other limitations to the current study include the lack of a
psychiatric control group, which limits the ability to determine if these
psychosocial patterns (i.e., QOL, depression, and anxiety) are specific
to those with HPD. Furthermore, some additional comorbidities were
not assessed, although none, other than personality disorders
(Chamberlain and Odlaug, 2014), have shown substantial comorbidity
with HPD. Another potential limitation of the current study is that the
QOLI may not be a highly valid measure for use in HPD. As noted by
Odlaug et al. (2010), although the QOLI assesses a range of topics
including self-esteem, it contains no question regarding appearance,
which can be particularly relevant for persons with HPD. Moreover, the
QOLI contains no age- or gender-based norms, factors which impact
quality of life (Hjermstad et al., 1998). Thus, the QOLI norms might
not accurately reflect quality of life in a sample consisting primarily of
middle-aged females. These caveats notwithstanding, this study
contributes substantially to the existing literature regarding
comorbidity patterns in HPD. Further research attention should be
directed toward comorbid and internalizing symptoms in hair pulling,
which might lead to more accurate conceptualizations of HPD clinical
presentation and associated impairment.
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